366 related articles for article (PubMed ID: 9566412)
1. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol.
Eldon MA; Underwood BA; Randinitis EJ; Sedman AJ
Neurology; 1998 Apr; 50(4):1146-8. PubMed ID: 9566412
[TBL] [Abstract][Full Text] [Related]
2. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Nayak RK
Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
[TBL] [Abstract][Full Text] [Related]
3. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
[TBL] [Abstract][Full Text] [Related]
4. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
Moutos D; Smith S; Zacur H
Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
[TBL] [Abstract][Full Text] [Related]
5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
6. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
[TBL] [Abstract][Full Text] [Related]
7. Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers.
Ouellet D; Hsu A; Qian J; Locke CS; Eason CJ; Cavanaugh JH; Leonard JM; Granneman GR
Br J Clin Pharmacol; 1998 Aug; 46(2):111-6. PubMed ID: 9723818
[TBL] [Abstract][Full Text] [Related]
8. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
Trapnell CB; Donahue SR; Collins JM; Flockhart DA; Thacker D; Abernethy DR
Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
Weisberg E; Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Nash HA
Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
[TBL] [Abstract][Full Text] [Related]
11. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
Wild RA; Demers LM; Applebaum-Bowden D; Lenker R
Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
Weisberg E; Fraser IS; Mishell DR; Lacarra M; Darney P; Jackanicz TM
Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484
[TBL] [Abstract][Full Text] [Related]
13. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception.
Contraception; 1980 May; 21(5):445-59. PubMed ID: 7428356
[TBL] [Abstract][Full Text] [Related]
15. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives.
Sinofsky FE; Pasquale SA
Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490
[TBL] [Abstract][Full Text] [Related]
16. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
Griffith SG; Dai Y
Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
[TBL] [Abstract][Full Text] [Related]
17. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
Coates PE; Mesure R
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
[TBL] [Abstract][Full Text] [Related]
18. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
[TBL] [Abstract][Full Text] [Related]
19. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
Hendrix CW; Jackson KA; Whitmore E; Guidos A; Kretzer R; Liss CM; Shah LP; Khoo KC; McLane J; Trapnell CB
Clin Pharmacol Ther; 2004 May; 75(5):464-75. PubMed ID: 15116059
[TBL] [Abstract][Full Text] [Related]
20. Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension).
Shulman LP; Oleen-Burkey M; Willke RJ
Contraception; 1999 Oct; 60(4):215-22. PubMed ID: 10640168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
